Medicine-assisted therapy is mostly therapy. Here's what preparation, the dosing session and integration involve in psychedelic-assisted therapy.
Medicine-Assisted Therapy and the Psychedelic Experience: What Actually Happens
Most coverage of psychedelic-assisted therapy focuses on the medicine. That makes sense, since it's the new and unusual part. But anyone who works in this field will tell you the medicine is only one piece. Psychedelic-assisted therapy is, first and foremost, therapy.
This guide explains how the process is structured in clinical settings, why each stage exists, and what the experience can look like from the inside.
Why "assisted" is the most important word
In the research model, a psychedelic is not a standalone treatment. It is given within a structured course of psychotherapy, and the therapy both surrounds and shapes the experience. Researchers often describe the medicine as something that opens a window of openness and emotional access. What a person does with that window depends heavily on the support around them.
This is why the field increasingly uses terms like medicine-assisted therapy. The emphasis sits on the therapeutic work, not the substance. Psychedelics are only a catalyst; the treatment requires commitment as well as hard work during all of therapy sessions and at home, in order to lead to benefits.
The four phases
1. Screening
Clinical programs assess for factors that make treatment unsuitable. These include for example a personal or family history of psychotic disorders, certain cardiovascular conditions or unsafe personal circumstances. Only those meeting all the criteria are admitted into treatment.
2. Preparation
Before any medicine session, a person typically has several sessions with their therapist. This phase builds trust, explores the person's history and intentions, and sets clear expectations about what might come up. It also covers practical matters: how the session will run, what support is available, and how to handle difficult moments.
3. The medicine session
The session itself usually takes place in a calm, controlled clinical room, with trained clinicians present for the full duration. People often lie down with an eye mask and a curated music playlist, and turn their attention inward.
Experiences vary widely. People describe vivid memories, strong emotions, a changed sense of self, moments of insight, and at times periods of fear or discomfort. Clinicians are trained not to steer the experience but to provide safety and support, especially through challenging moments.
4. Integration
Integration sessions follow the medicine session. This is where a person works with their therapist to make sense of what came up and translate it into lasting change in thinking, relationships and behaviour. Many clinicians consider integration the phase where much of the therapeutic benefit is consolidated. Integration can last weeks or months and happens as much in therapy sessions as it does at home.
The role of "set and setting"
"Set" refers to a person's mindset: expectations, mood, intentions. "Setting" refers to the environment, both physical and interpersonal. Decades of research suggest both strongly influence the experience. Clinical psychedelic-assisted therapy is essentially a disciplined way of attending to set and setting, which is one reason outcomes in clinical research differ so much from unsupervised use.
A balanced view of the evidence
Research into psychedelic-assisted therapy has grown rapidly, particularly for treatment-resistant depression and PTSD. It is still an emerging field. Trial design is hard (it is difficult to hide from participants whether they received an active medicine), and researchers continue to debate how large and durable the effects are. Outcomes are not always predictable and they are not always exactly what clients want them to be. This is important in light of the time, efforts and financial commitments that are required.
Frequently asked questions
Is psychedelic-assisted therapy the same as taking psychedelics recreationally?
No. Clinical programs involve screening, preparation, medically supervised sessions and structured integration, delivered by trained professionals. The experience and the risk profile differ substantially from unsupervised use.
How long does a medicine session last?
It depends on the medicine used. Sessions are typically a full day or a substantial part of one, with clinicians present throughout.
Can anyone access psychedelic-assisted therapy?
No. In Australia, access is tightly regulated and limited to specific conditions, specific prescribers and careful clinical assessment.
Is psychedelic-assisted therapy guaranteed to work?
No. The research is promising, particularly for treatment-resistant depression and PTSD, but it is still an emerging field. The outcomes depend on many factors and can never be fully predicted. It is worth weighing this against the time, effort and financial commitment involved.
How many therapy sessions are involved in total?
It varies between programs and clinicians. Most follow the same four phases of screening, preparation, a medicine session and integration, with several sessions during preparation and integration organised around each dosing session. Multiple dosing sessions are possible, but not one after another.
